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ABSTRACT
Huang, C-J., Pitt, H. A., Lipsett, P. A., Osterman Jr.,
F. A., Lillemoe, K. D., Cameron, J. L. and Zuiderma, G. D.
(1996) Pyogenic Hepatic Abscess: Changing trends over 42
years. Annals of surgery; 223: 600-609.
high, and proper management continues to be a cha-
llenge. Appropriate systemic antibiotics and fungal
agents as well as adequate surgical, percutaneous, or
biliary drainage are required for the best results.
Objective: The authors document changes in the
etiology, diagnosis, bacteriology, treatment, and
outcome of patients with pyogenic hepatic abscesses
over the past 4 decades.
Summary Background Data: Pyogenic hepatic ab-
scess is a highly lethal problem. Over the past 2
decades, new roentgenographic methods, such as
ultrasound, computed tomographic scanning, direct
cholangiography, guided aspiration, and percuta-
neous drainage, have altered both the diagnosis and
treatment of these patients. A more aggressive
approach to the management of hepatobiliary and
pancreatic neoplasms also has resulted in an
increased incidence of this problem.
Methods: The records of 233 patients with pyo-
genic liver abscesses managed over a 42-year period
were reviewed. Patients treated from 1952 to 1972
(n 80) were compared with those seen from 1973 to
1993 (n 153).
Results: From 1973 to 1993, the incidence increased
from 13 to 20 per 100,000 hospital admissions
(p<0.01). Patients managed from 1973 to 1993 were
more likely (p<0.01) to have an underlying malig-
nancy (52% vs. 28%) with most of these (81%) being
a hepatobiliary or pancreatic cancer. The 1973 to 1993
patients were more likely (p< .05) to be infected with
streptococcal (53% vs. 30%) or Pseudomonas (30% vs.
9%) species or to have mixed bacterial and fungal
(26% vs. 1%) infections. The recent patients also
were more likely (p<0.05) to be managed by
percutaneous abscess drainage (45% vs. 0%). Despite
having more underlying problems, overall mortality
decreased significantly (p<0.01) from 65% (in 1952 to
1972 period) to 31% (in 1973 to 1993 period). This
reduction was greatest for patients with multiple
abscesses (88% vs. 44%; p<0.05) with either a
malignant or a benign biliary etiology (90% vs.
38%; p<0.05). Mortality was increased (p<0.02) in
patients with mixed bacterial and fungal abscesses
(50%). From 1973 to 1993, mortality was lower
(p=0.19) with open surgical as opposed to percuta-
neous abscess drainage (14% vs. 26%).
Conclusions: Significant changes have occurred in
the etiiology, diagnosis, bacteriology, treatment, and
outcome of patients with pyogenic hepatic abscesses
over the past 4 decades. However, mortality remains
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PAPER DISCUSSION
Several series on pyogenic liver abscess (PLA)
have been published over the years since the
classic report by Ochsner and De Bakey in 1938
[1]. All have been retrospective reviews. These
have given considerable insight into the disease
pattern and progress made on the diagnostic as
well as therapeutic front. Recent series have
evaluated risk factors, prognostic factors, and
modern therapeutic strategies. Despite signifi-
cant progress with early diagnosis, improved
antibiotics and intensive supportive treatment,
pyogenic liver abscess still carries a significant
mortality.
Pyogenic liver abscess remains a rare disease.
Most published series in major institutions
averaged around 2 to 8 cases a year [2,3, 4,5, 6,
7,8,9,10]. Due to the relative rarity of the
condition, there has not been any prospective
randomised controlled trial looking at non-
operative treatment versus open surgical drai-
nage. A number of small series have shown
successful outcome using antibiotics alone or
antibiotics plus aspiration [11,12,13]. In other
series, antibiotics plus percutaneous drainage
has been associated with good results [2,3, 4, 7].
However, in some series an unfavourable out-
come has been reported using these non-
operative measures [5, 6] All of these series have
reported experiences with a small number of
patients.
Recently, a relative large retrospective review
of the treatment of pyogenic liver abscess at a66 HPB INTERNATIONAL
major centre has been reported. Huang et al. [14]
have reported their experience over a period of
forty-two years at John Hopkins Hospital. They
reviewed a current series of 153 patients over a
period of 21 years (1973- 1993) and compared it
with the experience of a previously published
series of 80 patients (1952- 1972) [15].
They noted an increase in incidence of PLA
during the second period (13 to 20 per 100,000
hospital admissions) and this was attributed to
an increase in the number of patients with
underlying malignancy (28% to 52%), and an
associated increase in the use of biliary stents for
the treatment of inoperable cancer. During the
same period, there was a significant reduction in
mortality (65% to 31%) which was attributed to
improvement in diagnosis and development of
percutaneous and non-operative biliary drai-
nage techniques. This improvement in mortality
is consistent with other recently published series
[4,5,6,7].
Liver malignancy and malignant biliary ob-
struction are the major causes of PLA as in other
series [2,5,6]. Of interest are the patients who
developed PLA after hepatic artery catheterisa-
tion for treatment of liver secondaries. This
complication had been previously reported
[16], and as in this series, it occurs despite use
of prophylactic antibiotics. The bacteriology of
the pyogenic abscess from nearly all series
indicated that the most likely organisms are
gram negative rods, and most likely to have an
enteric origin. Hence, these patients may be
predisposed to PLA as a result of either
decreased immunity or the necrosed tumour
becomes the perfect medium for enteric bacteria
to seed, probably via the portal venous system.
The bacteriology of the abscesses in this series
is similar to other major series, where enteric
organisms predominate. E Coli and Klebsiella
are by far the most common, followed by
streptococcus. In this series, the incidence of
streptococcus is greater as compared to the first
period. In addition, there was a high incidence of
resistant organisms present, probably due to
frequent use of antibiotics during stent mani-
pulation. A dramatic change has been the
occurrence of fungi in 26% of abscess cultures in
the second series compared to1% in the first series
and reflects the wide and frequent use of broad
spectrum antibiotics, particularly in patients with
stents who have frequent changes of the stents
and intermittent episodes of cholangitis.
High quality ultrasonography and CT scan-
ning have contributed to the greater accuracy of
diagnosis between the two periods reviewed.
However, cholangiography still remains a useful
investigation in up to 45% of patients. MRI has
not been shown to be useful, but it has not been
adequately evaluated.
The trend towards increasing use of percuta-
neous drainage of PLA and systemic antibiotics
is noted in recent series [2,3,4, 7, 8,11,13,17]. All
series adopted a selective approach with percu-
taneous aspiration or drainage coupled with
systemic antibiotics for selected cases of PLA. In
the John Hopkin’s series, percutaneous drainage
was not used in the first period. However, 45%
of the patients in the second period were treated
with percutaneous drainage. The overall mor-
tality has decreased significantly from 65% to
31% and this is attributed to better diagnosis,
improved antibiotics and the use of percuta-
neous approach. However, a comparison of the
mortality of patients having the percutaneous
approach(26%) versus open surgery (14%)
shows a trend favouring open surgery. The
authors noted that this apparent difference was
due to patient selection and that the higher
mortality in those patients having percutaneous
treatment was attributed to the underlying
disease (often a high cholangiocarcinoma) and
reflected the end stages of the disease.
The use of antibiotics alone in this series was
associated with 100% mortality reinforcing the
view that PLA, as with all abscesses, requires
drainage in addition to the use of appropriate
antibiotics.
Univariate analysis of risk factors was per-
formed. Risk factors found to be significant areHPB INTERNATIONAL 67
comparable to other series [3,8,18,19]. Risk
increases in the presence of multiple abscesses,
associated malignancy, jaundice, hypoalbumi-
naemia, leukocytosis, bilirubinaemia and the
presence of fungus infection.
This large series of patients with PLA treated
at a single major institution provides important
insight into the changing aetiology of this
disease. It has illustrated that it still remains as
a disease with high mortality, but often this
mortality reflects the end stage of the underlying
pathology. The trend away from open surgical
approaches is well illustrated, but the series also
shows that drainage needs to be achieved in
addition to the use of appropriate antibiotics.
There is a cautionary note regarding the use of
broad spectrum antibiotics in patient with
indwelling stents, as this practice has generated
fungal contamination of liver abscesses with
associated increased mortality. The drainage of
pyogenic abscess may be achieved via a percu-
taneous approach in most patients, but in
addition, biliary drainage and a combination of
laparoscopic plus percutaneous drainage may
have a place. In a selected group of patients,
resection of an infected segment of liver may be
the best and most conservative form of treat-
ment.
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